RETRACTED: MicroRNA-133a suppresses the proliferation, migration, and invasion of laryngeal carcinoma cells by targeting CD47 (Retracted Article)

被引:11
|
作者
Li, Hui [1 ]
Wang, Yan [2 ,3 ]
Li, Yan-Zhong [2 ,3 ]
机构
[1] 456 Hosp PLA, Dept Ophthalmol & Otorhinolaryngol, Jinan 250031, Peoples R China
[2] Shandong Univ, Qilu Hosp, Dept Otorhinolaryngol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China
[3] Minist Hlth, Dept Otorhinolaryngol, Key Lab Otolaryngol, 107 West Wenhua Rd, Jinan 250012, Shandong, Peoples R China
关键词
MicroRNA-133a; CD47; Laryngeal carcinoma; Proliferation; Invasion; Migration; Apoptosis; TUMOR SUPPRESSORS; MIR-133A; EXPRESSION; CANCER; ALCOHOL; FSCN1; HEAD;
D O I
10.1007/s13277-016-5451-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The study aims to investigate the possible mechanisms of microRNA-133a (miR-133a) targeting CD47 on cell proliferation, apoptosis, migration, and invasion in laryngeal carcinoma. Forty-two laryngeal carcinoma tissue specimens confirmed by pathological examination from laryngeal carcinoma patients as the case group were collected, and 20 chronic laryngitis tissues were gathered as the control group. The human laryngeal carcinoma cell line Hep-2 was marked as the miR-133a mimic, negative control (NC), miR-133a inhibitor, CD47-siRNA, miR-133a inhibitor + CD47-siRNA, and Mock groups. The expression of CD47 protein and miR-133a was detected by immunohistochemistry (IHC) and qRT-PCR. Dual luciferase assay system was used to determine the relationship between CD47 and miR-133a. Western blotting was used to measure the protein expression of CD47 andmiR-133a. 5-Ethynyl-2'-deoxyuridine (EDU) method was used to detect the cell proliferation, and flow cytometry and Transwell were used to measure the cell apoptosis and migration and invasion, respectively. The miR-133a expression in laryngeal carcinoma tissues was significantly lower, while the CD47 expression was higher than that in chronic laryngitis tissues (both P < 0.01). The expression of miR-133a in themiR-133a mimic group was significantly higher than that in other groups (P < 0.05), and the messenger RNA (mRNA) and protein expression of CD47 in the CD47-siRNA and miR-133a mimic groups were significantly lower than those in the Mock and NC group (all P < 0.05), while the mRNA and protein expression of CD47 in the miR-133a inhibitor group were higher than in other groups (all P < 0.05). After transfection, the CD47-siRNA group had the strongest inhibitory activity, while the number of living cells in the miR-133a inhibitor group was significantly higher than that in other groups (all P < 0.05). The apoptosis rates in the miR-133a mimic and CD47-siRNA groups were significantly higher than that in the Mock and NC groups (all P < 0.05). The cell numbers that penetrated membrane in the miR-133a mimic and CD47-siRNA groups were less than in theMock and NC groups (all P < 0.05). Upregulated miR-133a could inhibit proliferation, invasion, and migration and promote cell apoptosis in laryngeal carcinoma by targeting CD47. miR-133a targeting CD47 could be a new direction in the diagnosis and treatment of laryngeal carcinoma.
引用
收藏
页码:16103 / 16113
页数:11
相关论文
共 50 条
  • [1] RETRACTED: MicroRNA-25 suppresses proliferation, migration, and invasion of osteosarcoma by targeting SOX4 (Retracted Article)
    Chen, Bingpeng
    Liu, Jingjing
    Qu, Ji
    Song, Yang
    Li, Yuxiang
    Pan, Su
    [J]. TUMOR BIOLOGY, 2017, 39 (07)
  • [2] RETRACTED: MicroRNA-613 suppresses proliferation, migration and invasion of osteosarcoma by targeting c-MET (Retracted Article)
    Li, Xinyu
    Sun, Xufang
    Wu, Jing
    Li, Zhihong
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (12): : 2869 - 2879
  • [3] RETRACTED: MicroRNA-30a suppresses the proliferation, migration and invasion of human renal cell carcinoma cells by directly targeting ADAM9 (Retracted Article)
    Jiang, Lining
    Liu, Yabin
    Ma, Can
    Li, Binghui
    [J]. ONCOLOGY LETTERS, 2018, 16 (03) : 3038 - 3044
  • [4] RETRACTED: MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma (Retracted Article)
    Zhang, Wei
    Liu, Kai
    Liu, Songyang
    Ji, Bai
    Wang, Yingchao
    Liu, Yahui
    [J]. TUMOR BIOLOGY, 2015, 36 (12) : 9779 - 9788
  • [5] RETRACTED: MicroRNA-133a suppresses colorectal cancer cell invasion by targeting Fascin1 (Retracted article. See vol. 22, 2021)
    Zheng, Keyan
    Liu, Weicheng
    Liu, Ye
    Jiang, Congqing
    Qian, Qun
    [J]. ONCOLOGY LETTERS, 2015, 9 (02) : 869 - 874
  • [6] RETRACTED: Targeting survivin suppresses proliferation and invasion of retinoblastoma cells in vitro and in vivo (Retracted Article)
    Liu, Kuixiang
    Liu, Yuanyuan
    Zhao, Guiqiu
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (09): : 9352 - 9361
  • [7] MicroRNA-200a Promotes Phagocytosis of Macrophages and Suppresses Cell Proliferation, Migration, and Invasion in Nasopharyngeal Carcinoma by Targeting CD47
    Zhao, Yunteng
    Yu, Xiaoxiao
    Tang, Haocheng
    Han, Ri
    Wang, Xianwen
    Wang, Jianqi
    Wang, Ke
    Li, Gang
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [8] RETRACTED: MiRNA-211 suppresses cell proliferation, migration and invasion by targeting SPARC in human hepatocellular carcinoma (Retracted Article)
    Deng, Biao
    Qu, Lei
    Li, Jinfang
    Fang, Jiaqing
    Yang, Shouwen
    Cao, Zhongwei
    Mei, Zhechuan
    Sun, Xing
    [J]. SCIENTIFIC REPORTS, 2016, 6
  • [9] RETRACTED: MiR-144 suppresses cell proliferation, migration, and invasion in hepatocellular carcinoma by targeting SMAD4 (Retracted Article)
    Yu, Min
    Lin, Ye
    Zhou, Yu
    Jin, Haosheng
    Hou, Baohua
    Wu, Zhongshi
    Li, Zhide
    Jian, Zhixiang
    Sun, Jian
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 4705 - 4714
  • [10] RETRACTED: MicroRNA-138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF-1α (Retracted Article)
    Chen, Yao
    Cao, Ke
    Wang, Shaohua
    Chen, Jia
    He, Bin
    He, Gu
    Chen, Yong
    Peng, Bin
    Zhou, Jianda
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (06) : 2513 - 2518